DC Funds, LP
- SEC CIK
- 0001869028
- Latest filing
- Aug 14, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 12, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 3
- 0 vs. Q1 2022
- Portfolio value
- $7.25M
- −$447.0K (−5.8%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BRNSBarinthus Biotherapeutics plc. | ADS | 642,204 | $2.86M | 39.4% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 589,102 | $2.41M | 33.2% | 00.0% | Unchanged | History |
| TCRXTScan Therapeutics, Inc. | COM | 630,000 | $1.98M | 27.3% | 00.0% | Unchanged | History |